Referral: Parenteral iron-containing medicinal products, ferric carboxymaltose,ferric derisomaltose,ferric gluconate,ferric hydroxide polymaltose complex,iron dextran,iron sucrose Article 31 referrals Procedure started, 12/11/2026

Human medicines European public assessment report (EPAR): Riximyo, rituximab, Date of authorisation: 15/06/2017, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Rixathon, rituximab, Date of authorisation: 15/06/2017, Revision: 17, Status: Authorised

Article 57 product data

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)

Mandate and objectives for the Working Group of the MSSG on critical medicine supply security

Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2026, 09:00 (CET) to 20 November 2026, 13:00 (CET)

Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 10 November 2026, 09:30 (CET) to 10 November 2026, 13:00 (CET)

Webinar on Product Management Service (PMS) public API, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 December 2026, 10:00 (CET) to 7 December 2026, 12:00 (CET)

Agenda - HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations